The Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 pipeline drugs market research report outlays comprehensive information on the Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, and Undisclosed which include the indications Solid Tumor, Mantle Cell Lymphoma, and Unspecified. It also reviews key players involved in Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 targeted therapeutics development with respective active and dormant or discontinued products.
The Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 pipeline targets constitutes close to 42 molecules. Out of which, approximately 40 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, Phase 0, IND/ CTA Filed, Preclinical, and Discovery stages are 2, 3, 6, 1, 1, 19, and 8 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 1, and 1 molecule.
Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1 overview
Inactive tyrosine protein kinase transmembrane receptor ROR1 is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. ROR1 is a receptor for ligand WNT5A, which activates the downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling.
For a complete picture of Inactive Tyrosine Protein Kinase Transmembrane Receptor ROR1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.